New number-crunching has revealed that accepting Australia's notoriously low pricing for a medicine would cost a company more than an entire year's worth of local sales for that drug
The company has updated its culture sharpening how it competes, works and delivers in a faster, more competitive market and there's more to come
Less than two years after leaving Australia, this former long-time ANZ GM has already won another promotion, stepping into an important role
Survey of Aussie GPs finds accuracy and hallucination risk is considered a "major concern" when it comes to AI yet eight in 10 are using it anyway
Meeting a significant unmet need, this approval will provide broad access to a brain imaging product already recognised in international clinical guidelines
One of the world's best known pharmaceutical companies is reportedly changing its name and introducing a new slogan
Pharma launches a recruitment drive to find the company's next leader with a glowing reference from its departing GM
Pharma commissioned survey reveals low awareness about this chronic disease with symptoms often mistaken as stress associated with 'everyday living'
Among a raft of medicines added to the ARTG last week is the first generic of a Novartis drug that earned $113 million in pre-rebate PBS benefits over the past year.
More than 40 leaders gather to accelerate evidence-based action, as diagnoses of gynaecological cancers are set to rise 21 per cent over the next decade
The MAPA Medical Affairs Summit was told MA is like the 'middle child' of pharma in a robust debate about how best the function can unleash its true potential
The first funding from the Australian Cancer Research Program will assist children and young adults with cancer participate in global CAR-T trials
Five scientists and a Canadian-American actor behind big name drug discoveries have been recognised for their efforts at the 2026 Lasker Foundation Awards
An Australian patient suffered a torn oesophagus after using the counterfeit, which contained eight times the active ingredient used in a popular drug, sponsored by a rival company
Medical affairs heavyweights joined a panel at MAPA to outline how people can take the lead in their organisations whatever the title they have
After 11 years working for the same Big Pharma and almost four serving on the Board of the industry body, this executive is the latest leadership departure
Millions in funding will allow up to 200 people to access a drug currently in a Phase 2/3 trial, providing real-world clinical data from a broader population.
Nineteen days before the turn of the calendar, the Govt has announced the PBS listing of a new treatment for patients with a debilitating disease
Thirteen medical affairs professionals, some representing their teams, have been recognised for their outstanding contribution to the industry
Pharma sets an ambitious goal to establish a portfolio of more than 100 biosimilars by 2040, up substantially from the 13 it currently markets
Health Minister “very confident” that other immunotherapy drug makers will submit broad PBS listing submissions following in the footsteps of a drug he referred to as the 'Beast'
After 12 years, this well-known leader who has worked tirelessly for equity in cancer care is standing down with a successor already named
